| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2044-05-15 |
| Par Value | 0 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 133.72 |
| Coupon | 4.875 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 299.877 |
| Min. Piece | Login |
| Min. Increment | Login |
This Becton Dickinson & Co. corporate debenture has a 4.88% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 299.88 million USD and matures on May 15, 2044 with a last coupon date of FEB 28, 2020. |
Becton Dickinson & Co., founded in 1897 and headquartered in Franklin Lakes, New Jersey, is a global leader in medical technology aimed at advancing healthcare outcomes. The company develops and manufactures a wide range of medical devices, instrument systems, and reagents, prominently known for its innovations in diabetes care, medication management, and infection prevention.